raised $6.8 million in a Series A funding round led by Philips’ venture arm.

Philips Health Technology Ventures, Vesalius Biocapital III and Health Innovations also participated in the round. The funding will enable DEARhealth to scale its operations into more hospitals across the U.S. and to expand internationally with the opening of a new European headquarters in Amsterdam.

The DEARhealth platform uses AI to predict the most effective care pathways for patients with inflammatory bowel disease, chronic pain, liver and kidney diseases and ovarian cancer, with epilepsy and several more chronic conditions expected to be added to the platform soon. These pathways are designed to provide the lowest risk to patients, and can be adjusted by physicians based on changes in condition or unexpected test results.

More articles about AI:
IBM Watson Health VP Lisa Rometty steps down: 3 notes
Dell, Microsoft throw millions behind AI startups to ‘get a window on innovation’
Texas hospital uses AI for stroke care: 3 notes


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.





READ SOURCE

READ  Hong Kong-listed game developer jazzes up offerings with VR startup - Nikkei Asian Review

WHAT YOUR THOUGHTS

Please enter your comment!
Please enter your name here